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Abstract
Background:  Gamma-aminobutyric acid type A receptors (GABAA-Rs) are the major inhibitory
receptors in the mammalian brain and are modulated by a number of sedative/hypnotic drugs including
benzodiazepines and anesthetics. The significance of specific GABAA-Rs subunits with respect to behavior
and in vivo drug responses is incompletely understood. The γ 2 subunit is highly expressed throughout the
brain. Global γ 2 knockout mice are insensitive to the hypnotic effects of diazepam and die perinatally.
Heterozygous γ 2 global knockout mice are viable and have increased anxiety-like behaviors. To further
investigate the role of the γ 2 subunit in behavior and whole animal drug action, we used gene targeting to
create a novel mouse line with attenuated γ 2 expression, i.e., γ 2 knockdown mice.
Results: Knockdown mice were created by inserting a neomycin resistance cassette into intron 8 of the
γ 2 gene. Knockdown mice, on average, showed a 65% reduction of γ 2 subunit mRNA compared to
controls; however γ 2 gene expression was highly variable in these mice, ranging from 10–95% of normal.
Immunohistochemical studies demonstrated that γ 2 protein levels were also variably reduced.
Pharmacological studies using autoradiography on frozen brain sections demonstrated that binding of the
benzodiazepine site ligand Ro15-4513 was decreased in mutant mice compared to controls. Behaviorally,
knockdown mice displayed enhanced anxiety-like behaviors on the elevated plus maze and forced novelty
exploration tests. Surprisingly, mutant mice had an unaltered response to hypnotic doses of the
benzodiazepine site ligands diazepam, midazolam and zolpidem as well as ethanol and pentobarbital. Lastly,
we demonstrated that the γ 2 knockdown mouse line can be used to create γ 2 global knockout mice by
crossing to a general deleter cre-expressing mouse line.
Conclusion: We conclude that: 1) insertion of a neomycin resistance gene into intron 8 of the γ 2 gene
variably reduced the amount of γ 2, and that 2) attenuated expression of γ 2 increased anxiety-like behaviors
but did not lead to differences in the hypnotic response to benzodiazepine site ligands. This suggests that
reduced synaptic inhibition can lead to a phenotype of increased anxiety-like behavior. In contrast, normal
drug effects can be maintained despite a dramatic reduction in GABAA-R targets.
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Background
GABAA-Rs are the major inhibitory receptors in the mam-
malian central nervous system and can be modulated by a
number of sedative, hypnotic and anesthetic drugs [1].
GABAA-Rs are putatively pentameric complexes and are
members of a 'superfamily' of related ligand-gated ion
channels. There are a variety of subunit families that make
up GABAA-Rs; a total of seventeen distinct subunits have
been cloned, α 1–6, β 1–4, γ 1–3, δ , ε , π , and θ . Much is
known of the subunits that comprise GABAA-Rs, but the
contribution of individual subunits to in vivo drug
responses is only beginning to be understood, largely
through the use of genetically engineered mice [2-4].
The γ 2 subunit is highly expressed throughout developing
and adult brain and spinal cord, is a component of almost
60% of all GABAA-Rs [5,6], and is required for synaptic
clustering of GABAA-Rs [7]. In vitro electrophysiologic
studies have demonstrated an obligatory role of the γ 2
subunit for benzodiazepine responsiveness [8]. Gunther
et al. created and studied mice that globally lacked all γ 2
subunits of the GABAA-R [9]. Mice homozygous for the γ 2
knockout died in the perinatal period with rare survivors
reaching postnatal day 18. Knockouts appeared normal at
birth, but developed sensorimotor abnormalities charac-
terized by hyperactivity, impaired grasping and righting
reflex, and abnormal gait. Pharmacologically, knockout of
γ 2 resulted in a severe deficit in benzodiazepine binding
sites (~94% reduction compared to control) while GABA
binding sites were only slightly reduced. Behaviorally, in
the few mice that survived long enough to be tested,
diazepam failed to induce sedation and loss of the right-
ing reflex at doses that were fully effective in wild type
mice [9]. γ 2 heterozygous knockout mice were normally
viable, had a ~50% reduction in γ 2 protein levels, and dis-
played increased anxiety-like behaviors [10]. Drug
responses of heterozygous γ 2 global knockouts have not
been reported, except for the high efficacy of low
diazepam doses to induce anxiolysis [10].
We set out to make mice with markedly attenuated expres-
sion of the γ 2 gene (i.e., γ 2 knockdown mice) that would
be viable and therefore useful for studies of basic behav-
iors and drug induced responses. We used gene targeting
and embryonic stem cell technologies to create this mouse
line by inserting a neomycin resistance gene (NEO) into
intron 8 of the γ 2 genomic locus. Insertion of NEO into
intronic DNA has previously been used to create hypo-
morphic alleles of several genes [11-23]. In those studies,
expression of the hypomorphic allele ranged from 5–25%
of control; substantially lower than the 50% reduction
typically observed in heterozygous knockouts. The γ 2
knockdown mouse line described in the present report
had a highly variable reduction in γ 2 mRNA and protein
levels.  γ 2 knockdown mice were normally viable, had
increased anxiety-like behaviors, but did not differ in the
hypnotic response to benzodiazepines. In addition, since
exon 8 of the γ 2 gene was flanked by loxP sites in this
mouse line, these mice could also be converted into a glo-
bal knockout mouse by crossing to a general deleter Cre-
expressing transgenic mouse line.
Results
Production of gene targeted mice
Four out of 330 embryonic stem cell clones displayed the
predicted restriction fragment length polymorphisms
(data not shown) indicative of the targeting event pre-
sented in Fig 1A. Because the targeting event results in a γ 2
locus in which exon 8 is flanked by loxP sites, we refer to
this locus as being floxed (F) in contrast to the endog-
enous wild type allele (+). Two correctly targeted cell
lines, 26L6 and 26C8 yielded germ-line competent chi-
meric males. Chimeras were mated to C57BL/6J females.
Offspring that were +/F were interbred to produce +/+, +/
F, and F/F mice. Mice were genotyped at weaning using
Southern blot analysis as indicated in Fig 1B. In this anal-
ysis, Probe A hybridized to a 9.2 kB BglII fragment from
the wild type γ 2 allele and a 3.4 kB fragment from the tar-
geted allele. Of 724 mice genotyped, 196 (27%) were +/+,
372 (51%) were +/F, and 156 (22%) were F/F. These val-
ues are in accord with the 1:2:1 genotype frequency as
expected by Mendelian genetics. Thus, homozygous
floxed mice were normally viable. They were also healthy
and overtly indistinguishable from wild type mice.
Northern blot analysis
Semi-quantitative northern blots were used to compare
the amount of γ 2 mRNA in wild type and F/F animals.
Hybridization of adult brain RNA with a γ 2 cDNA probe
yielded an intense 2.8 kB band in wild type mice. In con-
trast, RNA from F/F mice hybridized less intensely in most
mice, however the attenuation within this group was
highly variable. A sample northern blot is shown in Figure
2A. We semi-quantitatively determined γ 2 mRNA
amounts by comparing γ 2 band densities between wild
type (n = 23) and F/F (n = 36) mice following normaliza-
tion with β -actin. To normalize results over four different
blots, the ratio of wild type band densities on each blot
was averaged and normalized to 100. All samples on each
blot were then compared to the average of wild type band
densities. Values are shown in Figure 2B. Mean wild type
ratio was 100 whereas mean ratio in F/F samples was 35
with high variability including several mice with values
that overlapped with wild type values. Thus, γ 2 mRNA lev-
els in knockdown mice were dramatically attenuated on
average, but the levels varied significantly between mice.
Immunohistochemistry
Immunohistochemical staining of sagittal sections
probed with a γ 2-specific antibody was used to assess γ 2BMC Neuroscience 2005, 6:30 http://www.biomedcentral.com/1471-2202/6/30
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Gene targeting of the γ 2 subunit of the GABAA-R and development of γ 2 knockdown mice Figure 1
Gene targeting of the γ 2 subunit of the GABAA-R and development of γ 2 knockdown mice. (A) Targeting strategy used to pro-
duce γ 2 knockdown mice. Relevant region of endogenous gene (+), targeting vector, correctly targeted knockdown γ 2 (F), and 
cre-recombined knockout alleles (f) are shown. Relative locations of relevant restriction sites, exons (numbered orange 
boxes), loxP sites (blue triangles), plasmid backbone (wavy line), and positive (NEO) and negative (PGK-TK) selection cassettes 
are shown. (B) Southern Blot analysis of BglII digested tail DNAs. Probe A hybridizes to a 9.2 kb BglII fragment from the wild 
type endogenous allele and a 3.4 kb BglII fragment from the targeted allele.
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Northern blot analysis Figure 2
Northern blot analysis. (A) Sample northern blot analysis of wild type (+/+) and homozygous knockdown (F/F) adult whole 
brain total RNA hybrizided with a γ 2 cDNA or a human β -actin probe as a loading control. (B) Densitometric analysis of north-
ern blots. The ratio of band density between γ 2 and β -actin hybridization for wild type (n = 23) and homozygous knockdown 
(n = 36) mice was plotted. On each individual blot, the ratio of wild type band densities was averaged and normalized to 100. 
All samples on each blot were then compared to the average of wild type band densities on that blot. A total of 4 different 
blots were included in this analysis. The horizontal bar in each column represents the mean for that genotype.
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protein amount and distribution in the brain. A sampling
of wild type (Fig 3A) and knockdown (Fig 3B) brain sec-
tions are displayed. In three of the four knockdown
mouse sections shown, there was a marked overall reduc-
tion of γ 2 immunoreactivity in all areas of the brain except
the outer layer of the olfactory bulb. However, staining
intensity was variable between knockdown mice, with
one having near wild type intensity (Fig. 3B, d). A total of
10 F/F mice were studied. Seven out of 10 had a marked
decrease in γ 2 staining compared to wild type controls,
and three out of 10 had near wild-type or intermediate
levels of staining. Adjacent sections from these same mice
showed no change in α 1 or β 2/3 immunoreactivity (CPM
and ALD, unpublished observations).
Pharmacological characterization
Autoradiography on brain cryostat sections with various
ligands binding to selective sites of the GABAA-R revealed
clear differences in the homozygous γ 2 knockdowns as
compared to heterozygous and wild type mice (Table 1).
Total flumazenil-sensitive [3H]Ro15-4513 binding to
benzodiazepine sites was reduced in the knockdown in
most brain regions. The reduced binding in the 5 mice
analyzed ranged on the average from 25 to 57%. In several
regions, the heterozygous mice also showed significant
reduction of the binding, but clearly less than the
homozygous knockdown samples. A small proportion of
the reduction in the total binding was apparently due to
reduction in diazepam-insensitive α 4 and α 6 subunit-
Immunohistochemical distribution of γ 2 subunit of the GABAA-R in sections from individual (A) wild type and (B) homozygous  knockdown mice Figure 3
Immunohistochemical distribution of γ 2 subunit of the GABAA-R in sections from individual (A) wild type and (B) homozygous 
knockdown mice. Note the high level of abundance of γ 2 immunoreactivity in olfactory bulb (OB), cerebral cortex (CC), hip-
pocampus (HP), substantia nigra (SN), and cerebellum (CB) of wild type samples. The amount of γ 2 is variably reduced in many 
brain regions of the knockdown samples.
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containing receptors, this component being mostly
affected in the cerebellar granule cell layer.
GABA-sensitive [3H]muscimol binding to GABA agonist
sites was not altered in any brain region (Table 1).
Picrotoxinin-sensitive [35S]TBPS binding to the GABAA-R
channels was little affected between the mouse lines: basal
binding was increased in the hippocampus and decreased
in the cerebellar granule cell layer of the homozygous γ 2
knockdowns (Table 1). The GABA-insensitive [35S]TBPS
binding was increased all over the brain, but this compo-
nent still made up less than 10% of the basal binding,
except for the cerebellar granule cell layer. There, the
GABA-insensitive component was 20% as compared to
10% in the heterozygous and wild type animals.
Behavioral characterization
We examined the behavioral phenotype of the knock-
down mice using the elevated plus maze and forced explo-
ration in a novel open field. The elevated plus maze is
widely used to assess anxiety-like behavior in response to
the aversive stimulus of an elevated exposed space. On
this test apparatus, knockdown mice had a 74% reduction
in open arm entries (Fig. 4A) and an 83% reduction in
time on open arms (Fig. 4B) compared to controls sug-
gesting an increase in anxiety-like behavior. In contrast,
knockdown mice had the same number of total arm
entries as wild types (Fig. 4C) indicating that an alteration
in locomotion does not account for the differences in anx-
iety-like behavioral measures on this assay.
Knockdown mice were also tested for behavioral response
to an aversive, brightly lit open field test apparatus using
the forced novelty exploration test. Knockdown mice had
a 28% reduction in locomotor activity compared to wild
type mice when placed into this test arena (Fig. 4D). This
reduction in exploratory behavior in the knockdown ani-
mals is also indicative of an increase in anxiety-like
behavior.
Knockdown of the γ 2 subunit did not alter hypnotic
responses to benzodiazepine site ligands or other seda-
tive/hypnotic drugs tested. We measured the loss of
Table 1: Autoradiographic analysis of GABAA receptor binding sites in horizontal sections of wild type and mutant mice.
BRAIN REGION
Ligand/
condition
Ctx Th Hi CPu IC Gr Mol
[3H]Ro15-4513, basal
+/+ mice 102 ± 3 53 ± 3 102 ± 1 52 ± 4 63 ± 7 93 ± 4 84 ± 4
+/F mice 97 ± 2 42 ± 2c 91 ± 3c 44 ± 3b 52 ± 7 74 ± 7b 72 ± 7a
F/F mice 77 ± 6c 23 ± 2c 68 ± 5c 30 ± 3c 38 ± 13b 59 ± 7a 62 ± 6c
[3H]Ro15-4513 + Diazepam 100 µM
+/+ mice 4.4 ± 0.3 4.0 ± 0.3 7.0 ± 0.4 3.7 ± 0.3 3.3 ± 0.2 56 ± 5 5.4 ± 1.0
+/F mice 3.8 ± 0.3a 3.5 ± 0.4 5.7 ± 0.5c 3.3 ± 0.3 3.3 ± 0.3 41 ± 5c 4.7 ± 0.9
F/F mice 3.1 ± 0.2c 2.8 ± 0.2c 4.3 ± 0.3c 2.8 ± 0.2c 2.9 ± 0.1a 13 ± 4c 3.7 ± 1.5
[3H]Muscimol, basal
+/+ mice 16 ± 2 20 ± 4 9.3 ± 1.3 11 ± 2 4.2 ± 0.6 94 ± 7 8.7 ± 2.3
+/F mice 18 ± 2 23 ± 3 10.0 ± 2.1 11 ± 2 3.9 ± 0.8 101 ± 8 8.6 ± 1.0
F/F mice 15 ± 3 23 ± 7 9.7 ± 3.0 11 ± 4 3.8 ± 0.6 89 ± 16 8.1 ± 3.8
[35S]TBPS, basal
+/+ mice 210 ± 26 583 ± 143 211 ± 30 257 ± 55 914 ± 41 641 ± 114 80 ± 25
+/F mice 271 ± 47 527 ± 110 248 ± 34 277 ± 31 866 ± 51 722 ± 140 73 ± 16
F/F mice 277 ± 57 460 ± 145 299 ± 43b 292 ± 50 829 ± 98 425 ± 32b 100 ± 30
[35S]TBPS + GABA 1 mM
+/+ mice 3.0 ± 2.0 14 ± 9 1.7 ± 1.8 0.4 ± 2.6 4.6 ± 2.2 67 ± 6 1.7 ± 1.8
+/F mice 7.0 ± 1.3a 29 ± 13 5.9 ± 1.6b 4.9 ± 0.4a 18 ± 5a 75 ± 12 0.7 ± 2.4
F/F mice 16 ± 2c 42 ± 16a 13 ± 2.0c 18 ± 3c 76 ± 12c 86 ± 13a 5.0 ± 2.2
The data are means ± standard deviations for 5 mice in each genotype, and are expressed as nCi/mg for 3H-ligands and as nCi/g for 35S-ligand. 
Significance of the difference from wild type (Tukey-Kramer test after ANOVA): aP < 0.05, bP < 0.01, cP < 0.001. Ctx, cortex; Th, thalamus; Hi, 
hippocampus; CPu, caudate putamen; IC, inferior colliculus; Gr, cerebellar granule cell layer; Mol, cerebellar molecular layer.BMC Neuroscience 2005, 6:30 http://www.biomedcentral.com/1471-2202/6/30
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righting reflex to assess the acute sensitivity to sedative/
hypnotic drugs; no significant differences were found in
response to injection of diazepam, midazolam, zolpidem,
ethanol, or pentobarbital (Fig. 5).
Production of γ 2 global knockout mice
The gene targeting strategy that we used to produce the γ 2
knockdown mice also resulted in the insertion of loxP
sites that flank exon 8 of the γ 2 gene (see Fig. 1A). To
determine if these loxP sites were functional in vivo, heter-
ozygous floxed γ 2 mice were mated to a general deleter
cre-expressing transgenic mouse line (JAX Laboratory,
stock #003376) where the cre transgene was driven by a
ubiquitously expressed human beta actin promoter [24].
Restriction fragment polymorphism analysis by Southern
blotting confirmed the deletion of genomic DNA between
Behavioral characterization of knockdown mice Figure 4
Behavioral characterization of knockdown mice. (A-C) Elevated plus maze. Knockdown mice (A) entered open arms less often 
and (B) for less time, however, (C) total entries into arms did not differ from wild type mice. (D) Knockdown mice were also 
less active in the forced exploration test. The bars are means ± SEM. *p < .01, **p < .001.
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loxP sites. As predicted from Fig. 1A, Probe A hybridized
to a 6.6 kb BglII fragment from the recombined knockout
allele (data not shown).
To determine if cre-mediated recombination and deletion
of exon 8 resulted in a null allele, mice hemizygous for the
cre transgene and heterozygous for the recombined γ 2
allele (+/f) were mated to mice heterozygous for the
floxed, non-recombined γ 2 allele (+/F). 10.2% (14 of
137) of offspring from this mating strategy were
homozygous for the recombined locus (f/f). This ratio is
in agreement with the 12.5% predicted from Mendalian
genetics. 13 of the 14 f/f mice died within three days of
birth. One f/f mouse survived until postnatal day 21. This
neonatal lethality of γ 2 f/f mice is consistent with those
found in the global γ 2 knockouts of Günther et al. [9]
Hypnotic sensitivity Figure 5
Hypnotic sensitivity. No significant differences in the hypnotic effects of ethanol, pentobarbital, zolpidem, midazolam, or 
diazepam were observed. The bars are means ± SEM.
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which also had a deletion of exon 8. Therefore, we con-
clude that cre-mediated recombination of the loxP sites
and deletion of exon 8 inactivates the γ 2 gene.
Discussion
Genetic dissection of the GABAA-R system is yielding
remarkable insights into GABAA-R biology and the
mechanisms of action of various drugs. Here we report the
establishment of a new GABAA-R mutant mouse model,
one with attenuated expression of the γ 2 subunit that
averages ~35% of normal levels. This novel γ 2 knockdown
model has several unique features that make it useful.
First, compared to global knockouts which die as
neonates [9], knockdown mice have normal viability. Sec-
ondly, the graded levels of expression of γ 2 (range 10–
95% of normal) in the mutant mice could be useful in
studies correlating phenotype with the amount of γ 2 pro-
tein present. Finally, global knockout mice can be created
from these mice by crossing to a Cre recombinase express-
ing global deleter mouse line. Therefore, the mice
reported here represent a useful addition to the rapidly
expanding arsenal of mice with genetic alterations in the
γ 2 subunit of the GABAA-R. In addition to homozygous
and heterozygous global γ 2 knockouts [9], conditional γ 2
knockout mice [25], knockin mice with a point mutation
in γ 2 that eliminates zolpidem and inverse agonist β -car-
boline sensitivity [26,27], global knockout of the long
splice variant of γ 2 [28], and transgenic mice that express
either the long or short splice variants of the γ 2 subunit
[29] have been described.
An important unexpected finding from this study was the
extremely variable degree to which the genetic alteration
of the γ 2 locus changed the amount of γ 2 product pro-
duced. This γ 2 knockdown model was produced by inser-
tion of NEO into intronic DNA. This strategy has been
used previously to create hypomorphic alleles [11-23].
Creation of hypomorphic alleles has been useful in deter-
mining function of the gene that has been targeted, espe-
cially in cases where complete disruption of the gene is
lethal [12,14-16]. Intronic insertion of NEO creates hypo-
morphic alleles either through cryptic splicing signals in
the NEO gene that lead to a frameshift or alterations in
splicing, or by down regulating gene expression through
an unknown mechanism [14-16]. In the majority of these
studies, the authors' reported a 5–25% level of expression
from the targeted gene. However, in none of these previ-
ously described hypomorphic alleles was extensive varia-
bility reported. The γ 2 targeted homozygous mice in this
study clearly display a wide range of γ 2 mRNA and protein
levels. Semi-quantitative northern blot analysis revealed
that 4 out of 5 homozygous knockdown mice showed, on
average, a 70% reduction of γ 2 mRNA levels, whereas 1
out of 5 mice had γ 2 mRNA at a level that was similar to
wild type. Immunohistochemical data were consistent
with northern blot data. The reason for this highly varia-
ble expression within homozygous knockdown mice has
yet to be determined. The mixed background of Strain
129S1/X1 and C57BL6/J may not be the cause given that
other studies have not observed substantial variability in
expression using similar background strains [11,18,20].
Gender as a cause of variability also is not likely given that
a set of three male knockdown siblings exhibited the full
range of γ 2 levels; one being near wild type levels, another
being at an intermediate level, and the third exhibiting
severely attenuated expression. Further study to determine
the cause of this variability needs to be undertaken. Nev-
ertheless, investigators who desire to create a hypomor-
phic allele by inserting NEO into intronic DNA should
take into consideration the variability of gene expression
observed in this study. The extent of variability may be
locus dependent.
Knockdown of γ 2 subunit containing GABAA-Rs resulted
in behavioral changes that are indicative of increased anx-
iety-like behavior. These mutant knockdown mice
showed reduced exploratory behavior for a novel open
field apparatus and the open arms of the elevated plus
maze. Similar changes have been observed in γ 2 global
heterozygous knockout mice [10]. Together, these results
strengthen the possibility that GABAA-R dysfunction may
be an underlying cause of anxiety disorders in humans.
These mutant mouse models may be useful for dissecting
the etiology of this pervasive condition and for develop-
ing effective therapeutic interventions.
As expected, brains from γ 2 knockdown mice demon-
strated significantly decreased binding of the benzodi-
azepine site ligand, Ro15-4513. This was expected since
benzodiazepine binding sites are located at the interface
of select alpha and γ 2 subunits of the GABAA-R [30]. The
reduction observed in Ro15-4513 binding agree with
those from global γ 2 knockout mice [9] in that deficiency
of the γ 2 subunit abolishes the binding of the benzodi-
azepine-site ligands. The global heterozygous γ 2 knockout
mice have a reduction in total [3H]Ro15-4513 binding in
most brain regions [31], and the present data on the γ 2
knockdown show a very similar pattern of reduced bind-
ing. However, the 5 knockdown brains that we examined
had actually a greater reduction in benzodiazepine bind-
ing than the γ 2 heterozygous global knockouts published
earlier [31]. Similar to the γ 2 heterozygous knockouts,
[3H]muscimol binding was not affected, indicating that
the reduction of the γ 2 subunit levels is not compensated
by increased δ  subunit that is largely responsible for the
[3H]muscimol binding signal in brain sections [32]. The
basal binding of the ion channel ligand [35S]TBPS is usu-
ally reduced and its sensitivity to GABA increased by addi-
tion of γ 2 subunits [31]. Both in the γ 2 heterozygous
global knockout and in our homozygous knockdown,BMC Neuroscience 2005, 6:30 http://www.biomedcentral.com/1471-2202/6/30
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TBPS binding was increased in some brain regions, and,
more consistently, there emerged a "GABA-insensitive"
receptor population with widespread distribution in the
brain. This indicates production of GABAA-Rs with an αβ
configuration. These receptors bind strongly the agonist
and have reduced channel conductance [33], perhaps
reflecting only partial agonist efficacy of GABA. This
would explain the reduced allosteric efficacy of GABA in
abolishing TBPS binding. In addition, these receptors
have most likely non-synaptic, non-clustered localization
as they lack the γ 2 subunit [10,33]. Therefore, the partially
γ 2 depleted mice may have brain region-selective altera-
tions in synaptic and extrasynaptic receptors, and the
reduced synaptic GABAA-R function might correlate with
the anxious phenotype. However, surprisingly, the high-
dose hypnotic effects of the benzodiazepine site ligands
diazepam, zolpidem and midazolam were unchanged in
the knockdown mice.
Several hypotheses can be generated to explain the dis-
crepancy between decreased benzodiazepine ligand bind-
ing and unchanged hypnotic effects. One possibility is
that only a threshold level of γ 2 containing GABAA-Rs are
required for hypnotic responses to benzodiazepines. Mice
that completely lack γ 2 had only 6% of benzodiazepine
binding compared to wild type mice and were insensitive
to the hypnotic effects of diazepam [9]. Likewise, mice
with a point mutation in γ 2 that eliminated response to
zolpidem eliminated the effects of this benzodiazepine
site ligand [26]. It seems likely that the 20–40% of benzo-
diazepine sensitive receptors that remain in the knock-
down mice are enough to mediate the hypnotic effect of
benzodiazepine site ligands. This is supported by positron
emission tomography studies in humans, in which only a
small proportion of the benzodiazepine sites need to be
occupied by lorazepam and zolpidem to induce clinical
effects such as sedation [34,35]. There may thus be spare
receptors that can be measured by biochemical techniques
but are not needed for whole animal pharmacological
effects. Another hypothesis is that knockdown of γ 2 does
not result in a proportional reduction in all γ 2 containing
GABAA-Rs. Recent studies conducted in knockin mice
with a point mutation at the benzodiazepine binding site
have attributed α 1 and α 2 containing GABAA-Rs to the
mediation of benzodiazepine-induced sedation and anxi-
olysis, respectively [4,36-38]. Perhaps γ 2 knockdown mice
have disproportionate decreases in non-α 1 containing
receptors, e.g., α 2 or α 3 containing receptor isoforms. It
may be possible that in our γ 2 knockdown mice, the
number of α 2β xγ 2 GABAA-Rs is greatly reduced while the
number of α 1β xγ 2 receptors is not, which remains to be
studied. This could be tested by immunohistochemical
methods using antibodies against α 2 and α 3 or by testing
for changes in zolpidem insensitive binding. Changes in
subunit trafficking may also play a role. Essrich et al. [7]
established strong evidence that GABAA-Rs are clustered at
the synapse through indirect interactions between γ 2 and
gephyrin. Enough clustering may remain in the knock-
down mice such that drug response does not change.
Alternatively, synaptic clustering of GABAA-Rs may not be
important for behavioral responses to benzodiazepines,
and it is possible that benzodiazepines potentiate the
extrasynaptic GABAA-R responses determined by electro-
physiology in brain slices [39]. It is also possible that the
high variability in γ 2 levels in the brain of knockdown
mice masked any change in behavioral response to these
drugs. In hindsight, it would have been useful to quantify
γ 2 levels in the same mice that were used for the behavio-
ral sensitivity studies. It would be interesting to see if sen-
sitivity correlated with γ 2 levels on an individual animal
basis. This type of approach could be exploited in future
studies of γ 2 receptor function. Lastly, decreases in benzo-
diazepine binding may not directly translate into changes
in  in vivo insensitivity. For example, in α 1 null mice,
changes in benzodiazepine binding did not change whole
animal sensitivity to midazolam but increased sensitivity
to diazepam [40,41]. In contrast, in mice that selectively
lack the long splice variant of γ 2, affinity for benzodi-
azepine site ligands is increased and behavioral response
to the sedative effects of midazolam and zolpidem is also
increased [42]. Similarly, in mice lacking the β 3 subunit,
decreased benzodiazepine binding and decreased whole
animal midazolam sensitivity were observed [43]. Further
study is required to examine these possibilities.
Conclusion
We have produced a novel genetically engineered mouse
line that exhibits a reduction in γ 2 mRNA levels that is
highly variable between mice (range 10–95% of control)
but averages ~35% of control levels. These γ 2 knockdown
mice are viable and have enhanced anxiety-like behavioral
abnormalities. Surprising, these mice are normally sensi-
tive to the hypnotic effects of benzodiazepine site ligands.
Lastly, this novel genetically engineered mouse line can
also be easily converted to a γ 2 global knockout mouse
line by simply crossing to a cre-expressing global deleter
transgenic mouse line.
Methods
Generation of genetically altered mice
A 13.6 kB BglII Strain 129/SvJ mouse genomic DNA frag-
ment containing Exons 8–10 of the GABAA-R γ 2 gene was
subcloned from a P1 phage clone (Genome Systems, St.
Louis, MO). An oligonucleotide containing a loxP site and
an EcoRV site was inserted into a NcoI site 647 bp 5' to
Exon 8. A blunted fragment containing a NEO resistance
gene with PGK-1 promoter and polyadenylation signals
(obtained from pPNT [44]) fused with a loxP site was
inserted into a HincII site 855 bp 3' of Exon 8. The NEO
gene was inserted in the opposite orientation to γ 2 tran-BMC Neuroscience 2005, 6:30 http://www.biomedcentral.com/1471-2202/6/30
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scription. A PGK driven thymidine kinase expression cas-
sette (obtained from pPNT [44]) was then cloned 3' to the
γ 2 genomic DNA. The targeting construct was linearized
with SalI and electroporated into R1 embryonic stem cells
[45] following previously described procedures [46].
G418 (270 µg/ml; Life Technologies, Gaithersburg, MD)
and gancyclovir (2 µM; Sigma) resistant cells were
screened for gene targeting by Southern blot analysis of
BglII digested genomic DNA. Fragments were hybridized
with a 5' probe that was external to the targeting construct
(see Fig. 1). Proper targeting of the γ 2 locus was confirmed
by Southern blot analysis of EcoRV and SstI digested
DNA. Additional Southern blot analysis with probes to
the neomycin cassette or internal to the 3' arm of the tar-
geting vector (with 1–3 restriction enzymes) were also
conducted (results not shown). All results were consistent
with a correctly targeted γ 2 locus.
Two correctly targeted embryonic stem cell clones (26C8
and 26L6) were microinjected into C57BL/6J blastocysts
to produce chimeric mice. Male chimeras were mated to
C57BL/6J females. Agouti offspring heterozygous for the
targeted allele (F/+) were interbred to produce mice that
were wild type (+/+), heterozygous, or homozygous
mutants (F/F). The mice used in studies reported here
were derived from the 26L6 ES cell clone. All mice were
housed under conditions of lights on at 07:00 and lights
off at 19:00.
Northern blot analysis
Ten to fourteen week old mice were sacrificed by cervical
dislocation. RNA was isolated from whole brain using Tri-
zol reagent (Invitrogen). 20 µg of total RNA was electro-
phoresed in a 1.9% formaldehyde/1% agarose gel and
blotted onto Hybond-N (Amersham Pharmacia). Blots
were first probed with a 32P-labeled γ 2 cDNA probe then
re-hybrizided with a control human β -actin probe (Clon-
tech). Autoradiographs were digitally photographed and
band densities were measured using Kodak 1D Image
Analysis Software. Ratio between density of γ 2 hybridiza-
tion versus actin hybridization was recorded.
Immunocytochemistry
The procedure has been described elsewhere [47]. Briefly,
wild type and homozygous mutants were deeply anesthe-
tized with Avertin and transcardially perfused with Dex-
tran-Phosphate Buffer (PB) then fixative consisting of
0.01M periodate/0.075M lysine/4% paraformaldehyde in
0.1M PB (pH 7.4). The brains were frozen and sliced in
parasaggital sections (25 µm) with a freezing microtome.
Slices were incubated overnight at 4°C with affinity-puri-
fied rabbit anti-γ 2 [48,49] in 0.1M PB (pH 7.4) with 0.3%
Triton X-100, at a concentration of (1:100). The sections
were processed using an avidin-biotin-peroxidase system
(Vectastain Elite; Novocastra, Burlingame, CA). Peroxi-
dase reaction was carried out with 3-3' diaminobenzidine
tetrahydrochloride in the presence of cobalt chloride and
nickel ammonium sulfate as chromogens and hydrogen
peroxide as oxidant. Controls were performed either by
omitting the primary antibody or by incubating the pri-
mary antibody with the corresponding peptide [50].
Pharmacology
Eight-week-old mice were sacrificed by decapitation and
whole brains were rapidly dissected out and frozen on dry
ice. For autoradiography, 14-µm horizontal serial cryostat
sections were cut from 5 mouse brains of each genotype,
thaw-mounted onto gelatin-coated object glasses, and
stored frozen under desiccant at -20°C. All experiments
were carried out in parallel fashion with respect to mouse
lines, eliminating any day-to-day variation between the
assays. The autoradiographic procedures for regional
localization of [3H]Ro 15-4513, [3H]muscimol, and
[35S]TBPS binding were as described in [51]. Briefly, sec-
tions were preincubated in an ice-water bath for 15 min in
50 mM Tris-HCl (pH 7.4) supplemented with 120 mM
NaCl in the [3H]Ro 15-4513 and [35S]TBPS autoradio-
graphic assays, and in 0.31 M Tris-citrate (pH 7.1) in the
[3H]muscimol assay. All radioligands were purchased
from Perkin Elmer Life Sciences, Inc. (Boston, MA, USA).
The final incubation in respective preincubation buffer
was performed with 6 nM [35S]TBPS at room temperature
for 90 min, assays with 10 nM [3H]muscimol at 0–4°C for
30 min, and assays with 10 nM [3H]Ro 15-4513 in the
presence and absence of 100 µM diazepam (Orion
Pharma, Espoo, Finland) at 0–4°C for 60 min. After incu-
bation, sections were washed 3 × 15 s or 2 × 30 s in an ice-
cold incubation buffer in [35S]TBPS and [3H]Ro 15-4513
or in [3H]muscimol assay, respectively. Sections were then
dipped into distilled water, air-dried under a fan at room
temperature, and exposed with plastic [3H]- or [14C]-
methacrylate standards to Kodak Biomax MR films for 1
to 8 weeks. Nonspecific binding was determined with 10
µM flumazenil (Hoffmann-La Roche, Basel, Switzerland),
100 µM picrotoxinin (Sigma) and 100 µM GABA (Sigma)
in [3H]Ro 15-4513, [35S]TBPS and [3H]muscimol assays,
respectively. Binding densities in the relevant brain areas
were quantitated with MCID M5-imaging software (Imag-
ing Research Inc., Ontario, Canada) and converted to nCi/
mg (for 3H) or nCi/g (for 35S) radioactivity values on the
basis of the simultaneously exposed standards.
The concentrations of [3H]muscimol (10 nM) and [3H]Ro
15-4513 (10 nM) were greater than or equal to the disso-
ciation constants for a range of recombinant and native
GABAA  receptors [8,52-54]. Therefore, the autoradio-
graphic images should represent the density rather than
affinity of binding sites.BMC Neuroscience 2005, 6:30 http://www.biomedcentral.com/1471-2202/6/30
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Hypnotic sensitivity
Drug induced hypnosis was assessed by measuring the
duration of the loss of righting reflex in response to vari-
ous sedative/hypnotic drugs. Diazepam (25 mg/kg;
Sigma), midazolam (45 mg/kg and 75 mg/kg; ESI Lederle,
Philadelphia, PA), pentobarbital (45 mg/kg; Abbott, Chi-
cago, IL), zolpidem (60 mg/kg; Searle, Malvern, PA) or
ethanol (3.5 mg/kg; Pharmco, Brookfield, CT) were
administered intraperitoneally to wild type and
homozygous mutants. Drugs were diluted in saline such
that the injection volume was 20 µL per gram body
weight. After losing the righting reflex, mice were placed
in a plastic V-shaped trough and the time was recorded.
When the mouse was able to right itself three times in 30
s, the measure of hypnotic effect was over. Body tempera-
ture was maintained with aid of a heat lamp. Assays were
performed in a blinded manner with respect to genotype.
Effect of genotype on the duration of the loss of righting
reflex was compared using Student's t-test.
Elevated plus-maze test
Basal anxiety-like behavior was tested using the elevated
plus-maze. All mice were between 7 and 9 weeks of age
and were tested between 09:00 and 11:00. Each mouse
was placed on the central platform of the maze, facing an
open arm and allowed to freely explore the maze for 5
min under ambient room light. Open-arm and closed-
arm entries and the cumulative time spent on the open
and closed arms was recorded. A mouse was considered to
be on the central platform or on an arm when all four
paws were within its perimeter. The percent open-arm
entries, total number of entries, and percent time in open-
arms was determined. Data were analyzed using one-way
ANOVA.
Forced exploration
Basal motor activity of mice was determined using the
forced exploration test. 8–10 week old mice were placed
into a walled arena (43.2 cm × 43.2 cm × 30.5 cm) for 5
min. Distance traveled (cm) was measured automatically
using an Activity Monitor (Med Associates, St. Albans,
VT). All tests were performed between 12:00 and 15:00.
Effect of genotype on basal motor activity was compared
using Student's t-test.
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